A股異動 | 寧德時代漲4% 市值重返萬億之上 加速推進北美市場
格隆匯9月26日丨寧德時代漲4%,報434.5元,總市值重返萬億元之上。公司官方宣佈與美國儲能技術平台和解決方案供應商FlexGen達成合作協議,將在三年時間內為FlexGen供應10GWh的先進儲能產品。公司將為FlexGen供應集裝箱式液冷儲能產品EnerC。該款產品兼具IP55防護等級和C5防腐等級,可完美適應多種極端天氣,同時滿足全系統20年安全可靠運行。目前,寧德時代和FlexGen在儲能系統項目方面的合作已超過2.5GWh。此次與FlexGen深化合作並達成供應協議,有助於公司為北美儲能項目供應重要設備,加速其在北美市場的發展。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.